LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Charles River Laboratories International Inc

Cerrado

Sector Salud

187.55 -1.68

Resumen

Variación precio

24h

Actual

Mínimo

186.83

Máximo

187.85

Métricas clave

By Trading Economics

Ingresos

27M

94M

Ventas

20M

1B

P/B

Media del Sector

24.27

103.001

BPA

2.8

Margen de beneficio

9.134

Empleados

20,000

EBITDA

19M

239M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+15.59 upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

33M

10B

Apertura anterior

189.23

Cierre anterior

187.55

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

114 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Charles River Laboratories International Inc Gráfico

Noticias Relacionadas

8 ago 2024, 10:30 UTC

Principales Noticias

Big Pharma Cuts R&D, Sending Shudders Through Industry -- Heard on the Street -- WSJ

23 mar 2024, 13:00 UTC

Principales Noticias

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

Comparación entre iguales

Cambio de precio

Charles River Laboratories International Inc Esperado

Precio Objetivo

By TipRanks

15.59% repunte

Estimación a 12 meses

Media 221 USD  15.59%

Máximo 250 USD

Mínimo 191 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Charles River Laboratories International Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

4

Comprar

7

Mantener

0

Vender

Puntuación técnica

By Trading Central

187.1 / 191.4Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Very Strong Bearish Evidence

Largo Plazo

Very Strong Bearish Evidence

Sentimiento

By Acuity

114 / 365 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.